Stock analysis · Bull Rankings model

GRDN analysis

Guardian Pharmacy Services Inc — Health Care. Scored on the same transparent 7-signal model behind the daily rankings.

★
GRDN
Guardian Pharmacy Services Inc · Health Care
FCF$76mC-
Rev+11.3%B
D/E0.17A-
P/E45.9xC
PEG4.08D
74Score
$38.59
1Y Target$44.38Near-term target
5Y Target$62.15Compound horizon
10Y Target$91.36Long-dated conviction
FCF$76mTTM · 03/26
C-
FCF $76m — barely positive; fragile cash position · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+11.3%TTM YoY
B
Revenue +11.3% — at or above S&P median
D/E0.17total
A-
D/E 0.17 — conservative leverage, strong balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/E45.9x
C
P/E 45.9 — rich valuation; execution risk material
PEG4.08proxy
D
PEG 4.08 — very expensive; pricing in best-case scenarios · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $2.4b. 7% off the 52-week high of $41.36. Revenue growing +11%, comfortably above the S&P median.
Moat
ROE 27% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Trailing P/E 46x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.6% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Horizon
1-3 yr $44.38 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $62.15 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $91.36 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · GRDN
Shares to buy
51
Position size
$1,968
3.9% of portfolio
Stop price
$28.94
25% below $38.59
$ at risk
$500.00
1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Analyze another ticker →